Please login to the form below

Not currently logged in
Email:
Password:

Actavis makes two additions to board of directors

Michael R Gallagher and Peter J McDonnell join

Actavis has elected Michael R Gallagher and Peter J McDonnell to its board of directors.

Both Gallagher and McDonnell are former members of the board of directors for Allergan, whom Actavis completed its acquisition of this week.

Brent Saunders, CEO and president and Actavis, commented: “The addition of Michael and Peter brings significant experience from Allergan to our board and I welcome their insights and expertise as we combine our two dynamic organisations.

“I want to thank the entire Allergan board for their stewardship to Allergan shareholders in building a strong and successful company.”

Gallagher was elected to the Allergan board in 1998 and served as its lead independent director and chair of the organisation and compensation committee. 

In 2004, he retired as CEO and director of Playtex products where he joined in 1995. Prior to this, he held a number of senior roles at companies including Procter & Gamble and Reckitt & Colman.

McDonnell was appointed to the Allergan board in 2013 and served on the corporate governance and compliance committee and the science and technology committee. 

He has served as the chief medical editor of Ophthalmology Times and his research interests include the causes and correction of refractive error, corneal wound healing and microbial keratitis. 

20th March 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics